DOI: 10.1074/mcp.r400007-mcp200. Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool

Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool

10.1074/mcp.r400007-mcp200

Crossref journal-article

Elsevier BV

Molecular & Cellular Proteomics (78)

Bibliography

Diamandis, E. P. (2004). Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool. Molecular & Cellular Proteomics, 3(4), 367â378.

Authors 1

Eleftherios P. Diamandis (first)

References 68 Referenced 515

10.1038/nrc1041 / Nature Rev. Cancer / The case for early detection. by Etzioni (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib2', 'first-page': '683', 'article-title': 'Clinical proteomics: Translating benchside promise into bedside reality.', 'volume': '1', 'author': 'Petricoin', 'year': '2002', 'journal-title': 'Nature Rev.'} / Nature Rev. / Clinical proteomics: Translating benchside promise into bedside reality. by Petricoin (2002)
10.1093/clinchem/47.10.1901 / Clin. Chem. / Proteomics in early detection of cancer. by Srinivas (2001)
10.1016/j.cccn.2003.08.008 / Clin. Chim. Acta / Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. by Marvin (2003)
10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0 / Electrophoresis / Recent advancements in surface-enhanced laser desorption/ionization time-of-flight-mass spectrometry. by Merchant (2000)
{'key': '10.1074/mcp.R400007-MCP200_bib6', 'article-title': 'ProteinChip clinical proteomics: Computational challenges and solutions.', 'volume': '81', 'author': 'Fung', 'year': '2002', 'journal-title': 'BioTechniques'} / BioTechniques / ProteinChip clinical proteomics: Computational challenges and solutions. by Fung (2002)
10.1006/bbrc.2002.6678 / Biochem. Biophys. Res. Commun. / The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. by Isaaq (2002)
{'key': '10.1074/mcp.R400007-MCP200_bib8', 'first-page': '149A', 'article-title': 'SELDI-TOF MS for diagnostic proteomics.', 'volume': '75', 'author': 'Isaaq', 'year': '2003', 'journal-title': 'Anal. Chem.'} / Anal. Chem. / SELDI-TOF MS for diagnostic proteomics. by Isaaq (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib9', 'first-page': '267', 'article-title': 'Proteomic applications for the early detection of cancer.', 'volume': '3', 'author': 'Wulfkuhle', 'year': '2003', 'journal-title': 'Nature Rev.'} / Nature Rev. / Proteomic applications for the early detection of cancer. by Wulfkuhle (2003)
10.1038/nrd891 / Nature Rev. Drug Discovery / Clinical proteomics: Translating benchside promise into bedside reality. by Petricoin (2002)
10.1517/phgs.4.4.463.22753 / Pharmacogenomics / Mass spectrometry-based clinical proteomics. by Pusch (2003)
10.5858/2002-126-1518-PATTMD / Arch. Pathol. Lab. Med. / Proteomic approaches to tumor marker discovery. by Raj (2002)
10.1373/clinchem.2003.022178 / Clin. Chem. / Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. by Chace (2003)
10.1016/S0009-9120(03)00105-X / Clin. Biochem. / Tandem mass spectrometry in the clinical chemistry laboratory. by Dooley (2003)
10.1542/peds.112.5.1005 / Pediatrics / Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: A cost-effectiveness analysis. by Venditti (2003)
10.1053/beem.2000.0058 / Baillieres Best Pract. Res. Clin. Endocrinol. Metab. / Test methods: Anabolics. by Saugy (2000)
10.1038/nature01511 / Nature / Mass spectrometry-based proteomics. by Aebersold (2003)
10.1053/beog.2002.0297 / Best Pract. Res. Clin. Obstet. Gynaecol. / Screening for ovarian cancer. by Menon (2002)
10.1046/j.1464-4096.2001.02461.x / Brit. J. U. Intl. / Neural network analysis of clinicopathological factors in urological disease: A critical evaluation of available techniques. by Finne (2001)
10.1007/s00120-003-0322-7 / Urologe A. / An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2–20 microg/l. by Stephan (2003)
10.1073/pnas.0530278100 / Proc. Natl. Acad. Sci. U. S. A. / Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. by Welsh (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib22', 'first-page': '2223', 'article-title': 'Parallel overexpression of seven kallikrein genes in ovarian cancer.', 'volume': '63', 'author': 'Yousef', 'year': '2003', 'journal-title': 'Cancer Res.'} / Cancer Res. / Parallel overexpression of seven kallikrein genes in ovarian cancer. by Yousef (2003)
10.1016/S0090-4295(00)00621-X / Urology / Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. by Makglara (2000)
{'key': '10.1074/mcp.R400007-MCP200_bib24', 'first-page': '5974', 'article-title': 'Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.', 'volume': '61', 'author': 'Welsh', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. by Welsh (2001)
10.1073/pnas.98.3.1176 / Proc. Natl. Acad. Sci. U. S. A. / Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. by Welsh (2001)
{'key': '10.1074/mcp.R400007-MCP200_bib26', 'first-page': '3695', 'article-title': 'The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.', 'volume': '63', 'author': 'Hellstrom', 'year': '2003', 'journal-title': 'Cancer Res.'} / Cancer Res. / The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. by Hellstrom (2003)
10.1001/jama.287.13.1671 / J. Am. Med. Assoc. / Osteopontin as a potential diagnostic biomarker for ovarian cancer. by Kim (2002)
10.1093/clinchem/48.8.1198 / Clin. Chem. / Human tissue kallikreins: A family of new cancer biomarkers. by Diamandis (2002)
{'key': '10.1074/mcp.R400007-MCP200_bib29', 'first-page': '184', 'article-title': 'The new human tissue kallikrein gene family: Structure, function and association to disease.', 'volume': '22', 'author': 'Yousef', 'year': '2001', 'journal-title': 'Endocr. Rev.'} / Endocr. Rev. / The new human tissue kallikrein gene family: Structure, function and association to disease. by Yousef (2001)
10.1016/S0140-6736(02)07746-2 / Lancet / Use of proteomic patterns in serum to identify ovarian cancer. by Petricoin III (2002)
10.1038/nm0803-980a / Nat. Med. / Proteomics delivers on promise of cancer biomarkers. by Powell (2003)
10.1002/pmic.200300470 / Proteomics / A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer’s disease. by Carrette (2003)
10.1002/pmic.200300478 / Proteomics / A poteintial cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jacob disease. by Guillaume (2003)
10.1097/01.SLA.0000064293.57770.42 / Ann. Surg. / Characterization of renal allograft rejection by urinary proteomic analysis. by Clarke (2003)
10.1126/science.300.5617.236 / Science / Recruiting genes, proteins for a revolution in diagnostics. by Service (2003)
10.1016/S0140-6736(02)09390-X / Lancet / Proteomic patterns in serum and identification of ovarian cancer. by Diamandis (2002)
10.1093/jnci/95.6.489 / J. Natl. Cancer Inst. / Re: Serum proteomic patterns for detection of prostate cancer. by Diamandis (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib38', 'series-title': 'Tietz Textbook of Clinical Chemistry', 'first-page': '674', 'author': 'Burtis', 'year': '1994'} / Tietz Textbook of Clinical Chemistry by Burtis (1994)
10.1093/jnci/94.20.1576 / J. Natl. Cancer Inst. / Serum proteomic patterns for detection of prostate cancer. by Petricoin III (2002)
{'key': '10.1074/mcp.R400007-MCP200_bib40', 'first-page': '3609', 'article-title': 'Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.', 'volume': '62', 'author': 'Adam', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. by Adam (2002)
10.1093/clinchem/48.10.1835 / Clin. Chem. / Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminated prostate cancer from nonprostate patients. by Qu (2002)
10.1097/01.ju.0000069431.95404.56 / J. Urol. / Diagnostic potential of serum proteomic patterns in prostate cancer. by Banez (2003)
10.1046/j.1464-410X.2003.04341.x / Brit. J. U. Intl. / Putative protein markers in the sera of men with prostatic neoplasms. by Lehrer (2003)
10.1073/pnas.2033602100 / Proc. Natl. Acad. Sci. U. S. A. / Identification of biomarkers for ovarian cancer using strong anion-exchange Proteinchips: Potential use in diagnosis and prognosis. by Kozak (2003)
10.1126/science.302.5649.1316 / Science / Public projects gear up to chart the protein landscape. by Service (2003)
10.1373/49.8.1272 / Clin. Chem. / Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics? by Diamandis (2003)
10.1038/sj.pcan.4500384 / Prostate Cancer Prostatic Dis. / Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. by Wright (1999)
{'key': '10.1074/mcp.R400007-MCP200_bib48', 'first-page': '6029', 'article-title': 'Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.', 'volume': '61', 'author': 'Xiao', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. by Xiao (2001)
{'key': '10.1074/mcp.R400007-MCP200_bib49', 'article-title': 'A panel of three potential biomarkers discovered from serum proteomic profiling improves sensitivity of CA125 in the detection of early stage ovarian cancer—A multi-institutional study', 'author': 'Zhang', 'year': '2003', 'journal-title': 'Proc. AACR'} / Proc. AACR / A panel of three potential biomarkers discovered from serum proteomic profiling improves sensitivity of CA125 in the detection of early stage ovarian cancer—A multi-institutional study by Zhang (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib50', 'first-page': '2904', 'article-title': 'Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry.', 'volume': '9', 'author': 'Ye', 'year': '2003', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry. by Ye (2003)
10.1016/S0090-4295(03)00036-0 / Urology / Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer. by Hlavaty (2003)
10.1158/1078-0432.CCR-0413-3 / Clin. Cancer Res. / Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. by Cho (2004)
{'key': '10.1074/mcp.R400007-MCP200_bib53', 'first-page': '427', 'article-title': 'Serum haptoglobin in patients with ovarian malignancies.', 'volume': '38', 'author': 'Mueller', 'year': '1971', 'journal-title': 'Obstet. Gynecol.'} / Obstet. Gynecol. / Serum haptoglobin in patients with ovarian malignancies. by Mueller (1971)
10.1016/0277-5379(84)90007-5 / Eur. J. Cancer Clin. Oncol. / Serum haptoglobin and alpha-1 glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients—A preliminary report. by Fish (1984)
10.1016/S0009-9120(84)90465-X / Clin. Biochem. / Changes in serum acute phase proteins in ovarian cancer patients receiving cis-diamminedichloroplatinum (CDDP) infusion therapy. by Fish (1984)
10.1373/49.8.1276 / Clin. Chem. / Counterpoint. The vision for a new diagnostic paradigm. by Petricoin III (2003)
10.1038/nature02046 / Nature / Global analysis of protein expression in yeast. by Ghaemmaghami (2003)
10.1073/pnas.0634629100 / Proc. Natl. Acad. Sci. U. S. A. / .Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. by Washburn (2003)
10.1021/pr030003l / J. Proteome Res. / Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. by Marshall (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib60', 'first-page': '6971', 'article-title': 'Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization (SELDI) and neural-network analysis: Identification of key issues affecting potential clinical utility.', 'volume': '63', 'author': 'Rogers', 'year': '2003', 'journal-title': 'Cancer Res.'} / Cancer Res. / Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization (SELDI) and neural-network analysis: Identification of key issues affecting potential clinical utility. by Rogers (2003)
10.1186/1471-2105-4-24 / B. M. C. Bioinformatics / A data review and re-assessment of ovarian cancer serum proteomic profiling. by Sorace (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib62', 'series-title': 'Bioinformatics Adv Access', 'first-page': '1', 'article-title': 'Reproducibility of SELDI-TOF protein patterns in serum: Comparing data sets from different experiments', 'author': 'Baggerly', 'year': '2004'} / Bioinformatics Adv Access / Reproducibility of SELDI-TOF protein patterns in serum: Comparing data sets from different experiments by Baggerly (2004)
10.1038/425905a / Nature / Written in blood. by Liotta (2003)
{'key': '10.1074/mcp.R400007-MCP200_bib64', 'series-title': 'Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications', 'first-page': '3', 'article-title': 'Tumor markers: Past, present and future', 'author': 'Diamandis', 'year': '2002'} / Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications / Tumor markers: Past, present and future by Diamandis (2002)
10.1056/NEJM198611273152201 / N. Eng. J. Med. / Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. by Fossel (1986)
10.1056/NEJM199004053221410 / N. Engl. J. Med. / NMR—Another cancer-test disappointment. by Shulman (1990)
10.1056/NEJM199004053221402 / N. Engl. J. Med. / Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. by Engan (1990)
10.1093/jnci/djh056 / J. Natl. Cancer Inst. / Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. by Diamandis (2004)

Dates

Type	When
Created	21 years, 5 months ago (March 1, 2004, 8:47 p.m.)
Deposited	4 years ago (July 30, 2021, 1:52 a.m.)
Indexed	5 days, 22 hours ago (Aug. 21, 2025, 2:25 p.m.)
Issued	21 years, 4 months ago (April 1, 2004)
Published	21 years, 4 months ago (April 1, 2004)
Published Print	21 years, 4 months ago (April 1, 2004)

Funders 0

None

BibTeX

@article{Diamandis_2004, title={Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool}, volume={3}, ISSN={1535-9476}, url={http://dx.doi.org/10.1074/mcp.r400007-mcp200}, DOI={10.1074/mcp.r400007-mcp200}, number={4}, journal={Molecular & Cellular Proteomics}, publisher={Elsevier BV}, author={Diamandis, Eleftherios P.}, year={2004}, month=apr, pages={367–378} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        21
      ]
    ],
    "date-time": "2025-08-21T18:25:54Z",
    "timestamp": 1755800754419
  },
  "reference-count": 68,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            4,
            1
          ]
        ],
        "date-time": "2004-04-01T00:00:00Z",
        "timestamp": 1080777600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    },
    {
      "start": {
        "date-parts": [
          [
            2020,
            10,
            12
          ]
        ],
        "date-time": "2020-10-12T00:00:00Z",
        "timestamp": 1602460800000
      },
      "content-version": "vor",
      "delay-in-days": 6038,
      "URL": "http://creativecommons.org/licenses/by/4.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  },
  "DOI": "10.1074/mcp.r400007-mcp200",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        3,
        2
      ]
    ],
    "date-time": "2004-03-02T01:47:03Z",
    "timestamp": 1078192023000
  },
  "page": "367-378",
  "source": "Crossref",
  "is-referenced-by-count": 515,
  "title": "Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool",
  "prefix": "10.1016",
  "volume": "3",
  "author": [
    {
      "given": "Eleftherios P.",
      "family": "Diamandis",
      "sequence": "first",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1074/mcp.R400007-MCP200_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "243",
      "DOI": "10.1038/nrc1041",
      "article-title": "The case for early detection.",
      "volume": "3",
      "author": "Etzioni",
      "year": "2003",
      "journal-title": "Nature Rev. Cancer"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib2",
      "first-page": "683",
      "article-title": "Clinical proteomics: Translating benchside promise into bedside reality.",
      "volume": "1",
      "author": "Petricoin",
      "year": "2002",
      "journal-title": "Nature Rev."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "1901",
      "DOI": "10.1093/clinchem/47.10.1901",
      "article-title": "Proteomics in early detection of cancer.",
      "volume": "47",
      "author": "Srinivas",
      "year": "2001",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1016/j.cccn.2003.08.008",
      "article-title": "Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry.",
      "volume": "337",
      "author": "Marvin",
      "year": "2003",
      "journal-title": "Clin. Chim. Acta"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "1164",
      "DOI": "10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0",
      "article-title": "Recent advancements in surface-enhanced laser desorption/ionization time-of-flight-mass spectrometry.",
      "volume": "21",
      "author": "Merchant",
      "year": "2000",
      "journal-title": "Electrophoresis"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib6",
      "article-title": "ProteinChip clinical proteomics: Computational challenges and solutions.",
      "volume": "81",
      "author": "Fung",
      "year": "2002",
      "journal-title": "BioTechniques"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "587",
      "DOI": "10.1006/bbrc.2002.6678",
      "article-title": "The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.",
      "volume": "292",
      "author": "Isaaq",
      "year": "2002",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib8",
      "first-page": "149A",
      "article-title": "SELDI-TOF MS for diagnostic proteomics.",
      "volume": "75",
      "author": "Isaaq",
      "year": "2003",
      "journal-title": "Anal. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib9",
      "first-page": "267",
      "article-title": "Proteomic applications for the early detection of cancer.",
      "volume": "3",
      "author": "Wulfkuhle",
      "year": "2003",
      "journal-title": "Nature Rev."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "683",
      "DOI": "10.1038/nrd891",
      "article-title": "Clinical proteomics: Translating benchside promise into bedside reality.",
      "volume": "1",
      "author": "Petricoin",
      "year": "2002",
      "journal-title": "Nature Rev. Drug Discovery"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1517/phgs.4.4.463.22753",
      "article-title": "Mass spectrometry-based clinical proteomics.",
      "volume": "4",
      "author": "Pusch",
      "year": "2003",
      "journal-title": "Pharmacogenomics"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "1518",
      "DOI": "10.5858/2002-126-1518-PATTMD",
      "article-title": "Proteomic approaches to tumor marker discovery.",
      "volume": "126",
      "author": "Raj",
      "year": "2002",
      "journal-title": "Arch. Pathol. Lab. Med."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "1797",
      "DOI": "10.1373/clinchem.2003.022178",
      "article-title": "Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.",
      "volume": "49",
      "author": "Chace",
      "year": "2003",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "DOI": "10.1016/S0009-9120(03)00105-X",
      "article-title": "Tandem mass spectrometry in the clinical chemistry laboratory.",
      "volume": "36",
      "author": "Dooley",
      "year": "2003",
      "journal-title": "Clin. Biochem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "1005",
      "DOI": "10.1542/peds.112.5.1005",
      "article-title": "Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: A cost-effectiveness analysis.",
      "volume": "112",
      "author": "Venditti",
      "year": "2003",
      "journal-title": "Pediatrics"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "DOI": "10.1053/beem.2000.0058",
      "article-title": "Test methods: Anabolics.",
      "volume": "14",
      "author": "Saugy",
      "year": "2000",
      "journal-title": "Baillieres Best Pract. Res. Clin. Endocrinol. Metab."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "DOI": "10.1038/nature01511",
      "article-title": "Mass spectrometry-based proteomics.",
      "volume": "422",
      "author": "Aebersold",
      "year": "2003",
      "journal-title": "Nature"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "469",
      "DOI": "10.1053/beog.2002.0297",
      "article-title": "Screening for ovarian cancer.",
      "volume": "16",
      "author": "Menon",
      "year": "2002",
      "journal-title": "Best Pract. Res. Clin. Obstet. Gynaecol."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "825",
      "DOI": "10.1046/j.1464-4096.2001.02461.x",
      "article-title": "Neural network analysis of clinicopathological factors in urological disease: A critical evaluation of available techniques.",
      "volume": "88",
      "author": "Finne",
      "year": "2001",
      "journal-title": "Brit. J. U. Intl."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "1221",
      "DOI": "10.1007/s00120-003-0322-7",
      "article-title": "An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2\u201320 microg/l.",
      "volume": "42",
      "author": "Stephan",
      "year": "2003",
      "journal-title": "Urologe A."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "3410",
      "DOI": "10.1073/pnas.0530278100",
      "article-title": "Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.",
      "volume": "100",
      "author": "Welsh",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib22",
      "first-page": "2223",
      "article-title": "Parallel overexpression of seven kallikrein genes in ovarian cancer.",
      "volume": "63",
      "author": "Yousef",
      "year": "2003",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "527",
      "DOI": "10.1016/S0090-4295(00)00621-X",
      "article-title": "Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.",
      "volume": "56",
      "author": "Makglara",
      "year": "2000",
      "journal-title": "Urology"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib24",
      "first-page": "5974",
      "article-title": "Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.",
      "volume": "61",
      "author": "Welsh",
      "year": "2001",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "1176",
      "DOI": "10.1073/pnas.98.3.1176",
      "article-title": "Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.",
      "volume": "98",
      "author": "Welsh",
      "year": "2001",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib26",
      "first-page": "3695",
      "article-title": "The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.",
      "volume": "63",
      "author": "Hellstrom",
      "year": "2003",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "1671",
      "DOI": "10.1001/jama.287.13.1671",
      "article-title": "Osteopontin as a potential diagnostic biomarker for ovarian cancer.",
      "volume": "287",
      "author": "Kim",
      "year": "2002",
      "journal-title": "J. Am. Med. Assoc."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "1198",
      "DOI": "10.1093/clinchem/48.8.1198",
      "article-title": "Human tissue kallikreins: A family of new cancer biomarkers.",
      "volume": "48",
      "author": "Diamandis",
      "year": "2002",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib29",
      "first-page": "184",
      "article-title": "The new human tissue kallikrein gene family: Structure, function and association to disease.",
      "volume": "22",
      "author": "Yousef",
      "year": "2001",
      "journal-title": "Endocr. Rev."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "572",
      "DOI": "10.1016/S0140-6736(02)07746-2",
      "article-title": "Use of proteomic patterns in serum to identify ovarian cancer.",
      "volume": "359",
      "author": "Petricoin III",
      "year": "2002",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "980",
      "DOI": "10.1038/nm0803-980a",
      "article-title": "Proteomics delivers on promise of cancer biomarkers.",
      "volume": "9",
      "author": "Powell",
      "year": "2003",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1486",
      "DOI": "10.1002/pmic.200300470",
      "article-title": "A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer\u2019s disease.",
      "volume": "3",
      "author": "Carrette",
      "year": "2003",
      "journal-title": "Proteomics"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "1495",
      "DOI": "10.1002/pmic.200300478",
      "article-title": "A poteintial cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jacob disease.",
      "volume": "3",
      "author": "Guillaume",
      "year": "2003",
      "journal-title": "Proteomics"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "660",
      "DOI": "10.1097/01.SLA.0000064293.57770.42",
      "article-title": "Characterization of renal allograft rejection by urinary proteomic analysis.",
      "volume": "237",
      "author": "Clarke",
      "year": "2003",
      "journal-title": "Ann. Surg."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "DOI": "10.1126/science.300.5617.236",
      "article-title": "Recruiting genes, proteins for a revolution in diagnostics.",
      "volume": "300",
      "author": "Service",
      "year": "2003",
      "journal-title": "Science"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "170",
      "DOI": "10.1016/S0140-6736(02)09390-X",
      "article-title": "Proteomic patterns in serum and identification of ovarian cancer.",
      "volume": "360",
      "author": "Diamandis",
      "year": "2002",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "489",
      "DOI": "10.1093/jnci/95.6.489",
      "article-title": "Re: Serum proteomic patterns for detection of prostate cancer.",
      "volume": "95",
      "author": "Diamandis",
      "year": "2003",
      "journal-title": "J. Natl. Cancer Inst."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib38",
      "series-title": "Tietz Textbook of Clinical Chemistry",
      "first-page": "674",
      "author": "Burtis",
      "year": "1994"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "1576",
      "DOI": "10.1093/jnci/94.20.1576",
      "article-title": "Serum proteomic patterns for detection of prostate cancer.",
      "volume": "94",
      "author": "Petricoin III",
      "year": "2002",
      "journal-title": "J. Natl. Cancer Inst."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib40",
      "first-page": "3609",
      "article-title": "Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.",
      "volume": "62",
      "author": "Adam",
      "year": "2002",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "1835",
      "DOI": "10.1093/clinchem/48.10.1835",
      "article-title": "Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminated prostate cancer from nonprostate patients.",
      "volume": "48",
      "author": "Qu",
      "year": "2002",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "442",
      "DOI": "10.1097/01.ju.0000069431.95404.56",
      "article-title": "Diagnostic potential of serum proteomic patterns in prostate cancer.",
      "volume": "170",
      "author": "Banez",
      "year": "2003",
      "journal-title": "J. Urol."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "DOI": "10.1046/j.1464-410X.2003.04341.x",
      "article-title": "Putative protein markers in the sera of men with prostatic neoplasms.",
      "volume": "92",
      "author": "Lehrer",
      "year": "2003",
      "journal-title": "Brit. J. U. Intl."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "12343",
      "DOI": "10.1073/pnas.2033602100",
      "article-title": "Identification of biomarkers for ovarian cancer using strong anion-exchange Proteinchips: Potential use in diagnosis and prognosis.",
      "volume": "100",
      "author": "Kozak",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "1316",
      "DOI": "10.1126/science.302.5649.1316",
      "article-title": "Public projects gear up to chart the protein landscape.",
      "volume": "302",
      "author": "Service",
      "year": "2003",
      "journal-title": "Science"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "1271",
      "DOI": "10.1373/49.8.1272",
      "article-title": "Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics?",
      "volume": "49",
      "author": "Diamandis",
      "year": "2003",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "264",
      "DOI": "10.1038/sj.pcan.4500384",
      "article-title": "Proteinchip\u00ae surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.",
      "volume": "2",
      "author": "Wright",
      "year": "1999",
      "journal-title": "Prostate Cancer Prostatic Dis."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib48",
      "first-page": "6029",
      "article-title": "Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.",
      "volume": "61",
      "author": "Xiao",
      "year": "2001",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib49",
      "article-title": "A panel of three potential biomarkers discovered from serum proteomic profiling improves sensitivity of CA125 in the detection of early stage ovarian cancer\u2014A multi-institutional study",
      "author": "Zhang",
      "year": "2003",
      "journal-title": "Proc. AACR"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib50",
      "first-page": "2904",
      "article-title": "Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry.",
      "volume": "9",
      "author": "Ye",
      "year": "2003",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib51",
      "doi-asserted-by": "crossref",
      "first-page": "1261",
      "DOI": "10.1016/S0090-4295(03)00036-0",
      "article-title": "Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer.",
      "volume": "61",
      "author": "Hlavaty",
      "year": "2003",
      "journal-title": "Urology"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib52",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "DOI": "10.1158/1078-0432.CCR-0413-3",
      "article-title": "Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.",
      "volume": "10",
      "author": "Cho",
      "year": "2004",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib53",
      "first-page": "427",
      "article-title": "Serum haptoglobin in patients with ovarian malignancies.",
      "volume": "38",
      "author": "Mueller",
      "year": "1971",
      "journal-title": "Obstet. Gynecol."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib54",
      "doi-asserted-by": "crossref",
      "first-page": "625",
      "DOI": "10.1016/0277-5379(84)90007-5",
      "article-title": "Serum haptoglobin and alpha-1 glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients\u2014A preliminary report.",
      "volume": "20",
      "author": "Fish",
      "year": "1984",
      "journal-title": "Eur. J. Cancer Clin. Oncol."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib55",
      "doi-asserted-by": "crossref",
      "first-page": "38",
      "DOI": "10.1016/S0009-9120(84)90465-X",
      "article-title": "Changes in serum acute phase proteins in ovarian cancer patients receiving cis-diamminedichloroplatinum (CDDP) infusion therapy.",
      "volume": "17",
      "author": "Fish",
      "year": "1984",
      "journal-title": "Clin. Biochem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib56",
      "doi-asserted-by": "crossref",
      "first-page": "1276",
      "DOI": "10.1373/49.8.1276",
      "article-title": "Counterpoint. The vision for a new diagnostic paradigm.",
      "volume": "49",
      "author": "Petricoin III",
      "year": "2003",
      "journal-title": "Clin. Chem."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib57",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "DOI": "10.1038/nature02046",
      "article-title": "Global analysis of protein expression in yeast.",
      "volume": "425",
      "author": "Ghaemmaghami",
      "year": "2003",
      "journal-title": "Nature"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib58",
      "doi-asserted-by": "crossref",
      "first-page": "3107",
      "DOI": "10.1073/pnas.0634629100",
      "article-title": ".Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae.",
      "volume": "100",
      "author": "Washburn",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib59",
      "doi-asserted-by": "crossref",
      "first-page": "361",
      "DOI": "10.1021/pr030003l",
      "article-title": "Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction.",
      "volume": "2",
      "author": "Marshall",
      "year": "2003",
      "journal-title": "J. Proteome Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib60",
      "first-page": "6971",
      "article-title": "Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization (SELDI) and neural-network analysis: Identification of key issues affecting potential clinical utility.",
      "volume": "63",
      "author": "Rogers",
      "year": "2003",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib61",
      "doi-asserted-by": "crossref",
      "first-page": "24",
      "DOI": "10.1186/1471-2105-4-24",
      "article-title": "A data review and re-assessment of ovarian cancer serum proteomic profiling.",
      "volume": "4",
      "author": "Sorace",
      "year": "2003",
      "journal-title": "B. M. C. Bioinformatics"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib62",
      "series-title": "Bioinformatics Adv Access",
      "first-page": "1",
      "article-title": "Reproducibility of SELDI-TOF protein patterns in serum: Comparing data sets from different experiments",
      "author": "Baggerly",
      "year": "2004"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib63",
      "doi-asserted-by": "crossref",
      "first-page": "905",
      "DOI": "10.1038/425905a",
      "article-title": "Written in blood.",
      "volume": "425",
      "author": "Liotta",
      "year": "2003",
      "journal-title": "Nature"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib64",
      "series-title": "Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications",
      "first-page": "3",
      "article-title": "Tumor markers: Past, present and future",
      "author": "Diamandis",
      "year": "2002"
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib65",
      "doi-asserted-by": "crossref",
      "first-page": "1369",
      "DOI": "10.1056/NEJM198611273152201",
      "article-title": "Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.",
      "volume": "315",
      "author": "Fossel",
      "year": "1986",
      "journal-title": "N. Eng. J. Med."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib66",
      "doi-asserted-by": "crossref",
      "first-page": "1002",
      "DOI": "10.1056/NEJM199004053221410",
      "article-title": "NMR\u2014Another cancer-test disappointment.",
      "volume": "322",
      "author": "Shulman",
      "year": "1990",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib67",
      "doi-asserted-by": "crossref",
      "first-page": "949",
      "DOI": "10.1056/NEJM199004053221402",
      "article-title": "Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.",
      "volume": "322",
      "author": "Engan",
      "year": "1990",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1074/mcp.R400007-MCP200_bib68",
      "doi-asserted-by": "crossref",
      "first-page": "353",
      "DOI": "10.1093/jnci/djh056",
      "article-title": "Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems.",
      "volume": "96",
      "author": "Diamandis",
      "year": "2004",
      "journal-title": "J. Natl. Cancer Inst."
    }
  ],
  "container-title": "Molecular &amp; Cellular Proteomics",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1535947620349033?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1535947620349033?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://syndication.highwire.org/content/doi/10.1074/mcp.R400007-MCP200",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        7,
        30
      ]
    ],
    "date-time": "2021-07-30T05:52:39Z",
    "timestamp": 1627624359000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1535947620349033"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  },
  "references-count": 68,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2004,
          4
        ]
      ]
    }
  },
  "alternative-id": [
    "S1535947620349033"
  ],
  "URL": "http://dx.doi.org/10.1074/mcp.R400007-MCP200",
  "relation": {
    "has-review": [
      {
        "id-type": "doi",
        "id": "10.3410/f.1018235.207688",
        "asserted-by": "object"
      }
    ]
  },
  "ISSN": [
    "1535-9476"
  ],
  "subject": [],
  "container-title-short": "Molecular &amp; Cellular Proteomics",
  "published": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  }
}